EAM Investors’s LeMaitre Vascular LMAT Stock Holding History

EAM Investors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-32,340	Closed	-$2.98M	–	307
2024 Q4	$2.98M	Sell	32,340 -634	-2%	-$61K	0.42%	121
2024 Q3	$3.06M	Buy	32,974 +11	+0%	+$953	0.46%	120
2024 Q2	$2.71M	Buy	+32,963	New	+$2.42M	0.44%	122
2023 Q3	–	Sell	-45,439	Closed	-$3.06M	–	339
2023 Q2	$3.06M	Buy	+45,439	New	+$2.77M	0.57%	47
2017 Q4	–	Sell	-77,156	Closed	-$2.89M	–	325
2017 Q3	$2.89M	Buy	77,156 +24,016	+45%	+$817K	0.38%	74
2017 Q2	$1.66M	Sell	53,140 -2,584	-5%	-$74.6K	0.27%	161
2017 Q1	$1.37M	Sell	55,724 -86,714	-61%	-$2.04M	0.22%	170
2016 Q4	$3.61M	Sell	142,438 -5,668	-4%	-$126K	0.48%	45
2016 Q3	$2.94M	Sell	148,106 -65,071	-31%	-$1.14M	0.39%	98
2016 Q2	$3.04M	Sell	213,177 -35,189	-14%	-$538K	0.46%	58
2016 Q1	$3.85M	Sell	248,366 -21,057	-8%	-$302K	0.6%	20
2015 Q4	$4.65M	Sell	269,423 -1,144	-0.4%	-$16.6K	0.61%	19
2015 Q3	$3.3M	Buy	270,567 +86,347	+47%	+$1.11M	0.52%	42
2015 Q2	$2.22M	Buy	+184,220	New	+$1.81M	0.26%	170

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM Investors's LMAT Position: Q1 2025 in Review

EAM Investors sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 32,340 shares — an estimated $2.98M sold.

EAM Investors first reported a position in LMAT in Q2 2015 and held it in 14 quarters. The position peaked at $4.65M in Q4 2015. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

EAM Investors reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
EAM Investors sold 32,340 LeMaitre Vascular shares in Q1 2025, an estimated $2.98M.
EAM Investors first reported a position in LeMaitre Vascular in Q2 2015 and held it in 14 quarters.
EAM Investors's LeMaitre Vascular position peaked at $4.65M in Q4 2015.
288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on EAM Investors's 13F filing for Q1 2025, filed 13 May 2025.